Key points are not available for this paper at this time.
In this Viewpoint, Peter Bach and colleagues distinguish 5 pricing reform proposals implied by the concept of value-based drug pricing and discuss the potential of each to ensure value in response to unsustainable drug price increases.
Kaltenboeck et al. (Mon,) studied this question.